New York, October 01, 2014 -- Moody's Investors Service commented that the increase in mesh litigation reserves announced by Endo International plc is credit negative for the company including the rated issuers Endo Luxembourg Finance I Company S.a.r.l., Endo Finance LLC and Endo Finance Co (collectively "Endo"). Endo's Corporate Family Rating is Ba3 and its ratings are under review for possible downgrade related to the company's recent proposal to acquire Auxilium Pharmaceuticals, Inc. Moody's rating review of Endo will consider the impact of mesh litigation outflows anticipated over the next several years.

Vollständigen Artikel bei Moodys lesen